To directly assess the requirement of HK2 for promoting tumor growth and invasion, si- and shRNA were used to transiently and stably knockdown HK2 in two PDAC cell lines, CFPAC-1-LUC and PANC-1 (Figure 2a). This evidence concerns the gene HK2 and neoplasm.